Glaukos Corporation(GKOS)

Description: Glaukos Corporation (Glaukos) is an ophthalmic medical technology company. The Company is engaged in the development and commercialization of products and procedures for the treatment of glaucoma. Glaukos has developed the micro-invasive glaucoma surgery (MIGS) for glaucoma treatment. It offers iStent, an MIGS device measuring one millimeter long and 0.33 millimeter wide. MIGS procedures involve the insertion of a micro-scale device from within the eye's anterior chamber through a small corneal incision. Glaukos is also engaged in developing a portfolio of micro-scale injectable therapies, including three pipeline products, namely, the iStent Inject, the iStent Supra and iDose. The iStent Inject includes two stents pre-loaded in an auto-injection inserter. The iStent Supra is designed to access an alternative drainage space within the eye. iDose is an implant that is designed to provide a sustained release of a prostaglandin drug to lower intraocular pressure in glaucoma patients.

---

Keywords: Medicine Surgery Medical Technology Ophthalmology Eye Implant Vision Glaucoma Ophthalmic Drainage Blindness Eye Surgery Incision Treatment Of Glaucoma Cornea Intraocular Pressure Minimally Invasive Glaucoma Surgery Glaucoma Treatment

---

Home Page: www.glaukos.com

GKOS Technical Analysis

229 Avenida Fabricante
San Clemente, CA 92672
United States
Phone: 949 367 9600

---

Officers

Exchange: NYSE

Country: US

Currency: US Dollar ($)